Suppr超能文献

关于牛乳铁蛋白应用的25年研究

Twenty-five years of research on bovine lactoferrin applications.

作者信息

Tomita Mamoru, Wakabayashi Hiroyuki, Shin Kouichirou, Yamauchi Koji, Yaeshima Tomoko, Iwatsuki Keiji

机构信息

Dairy Techno Inc., 2-3-9 Shiba, Minato-ku, Tokyo 105-0014, Japan.

出版信息

Biochimie. 2009 Jan;91(1):52-7. doi: 10.1016/j.biochi.2008.05.021. Epub 2008 Jun 10.

Abstract

Lactoferrin (LF) was identified as a milk protein in 1960. Large-scale manufacturing of bovine LF (bLF) was established more than 20 years ago. Using this commercially available material, research for bLF applications has advanced from basic studies to clinical studies, and bLF has been applied to commercial food products for the last 25 years. During this period, it was found that LF is digested by gastric pepsin to generate a multi-potent peptide, lactoferricin. It was also demonstrated that oral administration of bLF augments host protection against infections via antimicrobial action and immunomodulation of the host. In addition, researchers have demonstrated that oral administration of bLF prevents cancer development. In this review, we look back on 25 years of bLF research and development.

摘要

乳铁蛋白(LF)于1960年被鉴定为一种乳蛋白。20多年前就建立了牛乳铁蛋白(bLF)的大规模生产。利用这种市售材料,对bLF应用的研究已从基础研究推进到临床研究,并且在过去25年中bLF已应用于商业食品。在此期间,发现LF被胃蛋白酶消化产生一种多能肽,即乳铁素。还证明口服bLF可通过抗菌作用和宿主免疫调节增强宿主对感染的保护。此外,研究人员已证明口服bLF可预防癌症发展。在本综述中,我们回顾了bLF 25年的研发历程。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验